Ken Griffin Semler Scientific, Inc. Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$28.42 - $51.54 $907,024 - $1.64 Million	31,915 New	31,915 $932,000
Q3 2023 Nov 14, 2023	SELL	$23.15 - $28.54 $327,595 - $403,869	-14,151 Reduced 52.06%	13,029 $330,000
Q2 2023 Aug 14, 2023	SELL	$22.5 - $30.58 $264,577 - $359,590	-11,759 Reduced 30.2%	27,180 $713,000
Q1 2023 May 15, 2023	BUY	$19.28 - $41.74 $750,743 - $1.63 Million	38,939 New	38,939 $1.04 Million
Q3 2022 Nov 14, 2022	BUY	$27.75 - $45.8 $614,773 - $1.01 Million	22,154 New	22,154 $832,000

3.27M

Ticker SMLR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 6,800,580
Market Cap $160M
Description
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's va...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.